ANTI-CSC COMBINATION THERAPY USING WNT SIGNALING-TARGETED DRUG
Dysfunctions of Wnt, Hedgehog and Notch pathways are evident in multiple tumor types and malignancies. A number of studies have suggested that dysregulation of Wnt/β-catenin signaling occurs in human breast cancer. Specifically, inhibition of Wnt/ β-catenin pathway is implicated in arresting of cancer stem cells (CSCs), a small subset of cancer cells capable of self-renewal and differentiation into heterogeneous tumor cells. Here, we investigated tumor initiating property of breast cancer stem cell in-vitro with XAV-939 an inhibitor of Wnt/β-catenin signaling pathway. Targeting Wnt/β-catenin signaling with this inhibitor represents a promising strategy to suppress metastasis.
Keywords: Cancer Stem Cell, 3D Mammosphere, Wnt/β-catenin, metastasis, CD44+/CD24
2. DeSantis CE., Bray F., Ferlay J., et al. International variation in female breast cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev, 2015; 24(10):1495–1506.
3. Hashim D., Boffetta P., La Vecchia C., et al. The global decrease in cancer mortality: trends and disparities. Ann Oncol, 2016; 27(5):926–933.
4. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet, 2012; 380(9855): 1778–1786.
5. Pace LE., Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA, 2014; 311(13):1327–1335.
6. Moja L., Tagliabue L., Balduzzi S., et al. Trastuzumab containing regimens for early breast cancer. Cochrane Database Syst Rev, 2012; 4:CD006243.
7. Koury J., Zhong L., Hao J. Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment. Stem Cells International, 2017; 2017:2925869. doi:10.1155/2017/2925869.
8. Hermann P.C., et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 2007; 1:313–23.
9. Mani S.A., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 2008; 133:704–15.
10. Howard B., Ashworth A. Signaling pathways implicated in early mammary gland morphogenesis and breast cancer. PLoS Genet, 2006; 2:e112.
11. Basu S., Haase G., Ben-Ze'ev A. Wnt signaling in cancer stem cells and colon cancer metastasis. F1000 Research, 2016; 5(699).
12. Mukherjee S., Mazumdar M., Chakraborty S., et al. Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loop. Stem Cell Research and Therapy, 2014; 5 (5):116.
13. Reya T., Duncan A. W., Ailles L., et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 2003; 423(6938):409–414.
14. Zhang X., Lou Y., Wang H., et al. Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells. Medical Oncology. 2015; 32(4): 95.
15. Vasanthakumar S., Sasikala P., Padma M., et al. EpCAM as a novel therapeutic target for hepatocellular carcinoma. Journal of Oncological Sciences, 2007; 3:71-76.
16. Malanchi I., Peinado H., Kassen D., et al. Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling. Nature, 2008; 452(7187):650–653.
17. Jang GB., Kim JY., Cho SD., Park KS., Jung JY., Lee HY., et al. Blockade of Wnt/beta-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype. Sci Rep, 2015; 5:12465.
18. Al-Hajj M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J. & Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci, 2003; USA100:3983–8.
19. Liu, H et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci, 2010; USA107:18115–20.
20. Zardawi S.J., O’Toole S.A., Sutherland R.L. & Musgrove, E.A. Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. Histol Histopathol, 2009; 24:385–98.
21. Lopez-Knowles E.et al. Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients. Cancer Epidemiol Biomarkers Prev, 2010; 19:301–9.
22. Xiao-Hong T., Wei-Jian H. Yan F., et al. XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway. J Exp & Clin Cancer Res, 2013; 32:100.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).